A2A Pharmaceuticals, Inc.

Insider Reports History

Location
New York, NY
Signature
Edward Painter
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by A2A Pharmaceuticals, Inc.:

Company Role Class Num Shares Value Price $ Report Date Ownership
Biomea Fusion, Inc. 10%+ Owner Common Stock 3,500,000 $13,238,750 $3.78 01 Jun 2023 Direct

Insider Reports Filed by A2A Pharmaceuticals, Inc.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BMEA Biomea Fusion, Inc. 31 May 2023 2 -$4,263,915 4 10%+ Owner 02 Jun 2023, 17:00
BMEA Biomea Fusion, Inc. 12 May 2023 1 -$846,000 4 10%+ Owner 17 May 2023, 07:13
BMEA Biomea Fusion, Inc. 08 May 2023 2 -$8,575,030 4 10%+ Owner 10 May 2023, 17:19
BMEA Biomea Fusion, Inc. 20 Apr 2023 1 -$5,823,760 4 10%+ Owner 26 Apr 2023, 08:36
BMEA Biomea Fusion, Inc. 31 Mar 2023 1 -$6,250,000 4/A 10%+ Owner 06 Apr 2023, 19:31
BMEA Biomea Fusion, Inc. 31 Mar 2023 1 +$6,250,000 4 10%+ Owner 06 Apr 2023, 18:43
BMEA Biomea Fusion, Inc. 16 Aug 2022 1 -$425,648 4 10%+ Owner 19 Aug 2022, 06:56
BMEA Biomea Fusion, Inc. 21 Jul 2022 1 -$388,516 4 10%+ Owner 25 Jul 2022, 19:16
BMEA Biomea Fusion, Inc. 24 Jun 2022 1 -$407,578 4 10%+ Owner 28 Jun 2022, 07:51
BMEA Biomea Fusion, Inc. 17 Sep 2021 1 +$379,852 4 10%+ Owner 21 Sep 2021, 16:05